Answers are grounded in this paper and cite their sources.
Sickle cell disease (SCD) places a lifelong burden on patients and family members. Our objective was to review the available evidence to understand the impact of SCD across the life course, including childhood development, education, employment, quality of life, and life expectancy. This targeted literature review examined empirical studies from 2001 to 2026 that assessed the burden of SCD among patients and family caregivers across different life stages, including childhood, adolescence, adulthood, and older adulthood. Outcomes included early childhood development, education, labor market outcomes, life expectancy, and impact on family caregivers. Overall, 23 unique studies were included. Studies consistently demonstrated that SCD places a large burden on patients and family caregivers across all life stages, especially for those with recurrent vaso-occlusive crises. Many children with SCD experience significant developmental delays in cognition, while adolescents often experience greater school absenteeism, worse academic performance, and a higher likelihood of school dropout. Caregivers for children with SCD experience lost labor market opportunities and diminished mental health. Adults with SCD are less likely to work (unemployment), and when they do, they often have greater work absenteeism and presenteeism, worse job opportunities, and less income. Ultimately, people with SCD experience both lower overall life expectancy and lower quality of life. Patients with SCD experience a burden associated with the disease across the life course. These outcomes should inform future evaluations of treatment and supportive services for SCD, which have the potential to generate substantial societal value.
No takes yet. Share an insight, caveat, or question.
Grabowski et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: